Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Parallel Session 3409

Seeing RED: Update on Repeat Expansion Disorders

Sunday, September 29, 2024
15:00 - 17:00

In this session the faculty, will provide an update on the phenotypic spectrum of repeat expansion disorders and will explain the principles of how identifying new genes can lead to new treatments.


Chairs:
Sylvia Boesch, Austria
David Lynch, USA

Newly Described Ataxias
Achal Kumar Srivastava, India

Update on FCMTE
Hiroyuki Ishiura, Japan

Molecular Mechanisms and Emerging Treatments
Henry Houlden, United Kingdom

CSPC Liaisons:
Huw Morris, United Kingdom

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Describe new, common repeat expansion ataxias such as RFC1 (CANVAS) and FGF14
  2. Describe new knowledge on familial epilepsy/tremor syndromes
  3. Describe how knowledge on molecular mechanisms can lead to the identification of new treatment targets

Recommended Audience
Clinician
Fellow / Resident / Student
Industry
Researcher / Basic Science

Education Level
Experienced / Intermediate
Expert / Advanced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice